(4R,5S,6S,7R,9R,11E,15S,16R)-7-(2-Hydroxyethyl)-5,9,13,15-tetramethyl-16-ethyl-4-hydroxy-6-[3-(dimethylamino)-3,4,6-trideoxy-β-D-xylo-hexopyranosyloxy]-1-oxacyclohexadeca-11,13-diene-2,10-dione
|
|
(4R,5S,6S,7R,9R,11E,15S,16R)-7-(2-Hydroxyethyl)-5,9,13,15-tetramethyl-16-ethyl-4-hydroxy-6-[3-(dimethylamino)-3,4,6-trideoxy-β-D-xylo-hexopyranosyloxy]-1-oxacyclohexadeca-11,13-diene-2,10-dione Eigenschaften
- Siedepunkt:
- 729.2±60.0 °C(Predicted)
- Dichte
- 1.13±0.1 g/cm3(Predicted)
- pka
- 13.49±0.70(Predicted)
Sicherheit
(4R,5S,6S,7R,9R,11E,15S,16R)-7-(2-Hydroxyethyl)-5,9,13,15-tetramethyl-16-ethyl-4-hydroxy-6-[3-(dimethylamino)-3,4,6-trideoxy-β-D-xylo-hexopyranosyloxy]-1-oxacyclohexadeca-11,13-diene-2,10-dione Chemische Eigenschaften,Einsatz,Produktion Methoden
(4R,5S,6S,7R,9R,11E,15S,16R)-7-(2-Hydroxyethyl)-5,9,13,15-tetramethyl-16-ethyl-4-hydroxy-6-[3-(dimethylamino)-3,4,6-trideoxy-β-D-xylo-hexopyranosyloxy]-1-oxacyclohexadeca-11,13-diene-2,10-dione Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(4R,5S,6S,7R,9R,11E,15S,16R)-7-(2-Hydroxyethyl)-5,9,13,15-tetramethyl-16-ethyl-4-hydroxy-6-[3-(dimethylamino)-3,4,6-trideoxy-β-D-xylo-hexopyranosyloxy]-1-oxacyclohexadeca-11,13-diene-2,10-dione Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 2)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Zhejiang Huida Biotech Co., LTD | 0571-89903882 15990081639 |
sunshixuan@huidabiotech.com | China | 3644 | 58 |
Zhejiang Huida Biotech Co., LTD | 0571-0571-89903882 15990081639 |
sunshixuan@huidabiotech.com | China | 3705 | 58 |
- (4R,5S,6S,7R,9R,11E,15S,16R)-7-(2-Hydroxyethyl)-5,9,13,15-tetramethyl-16-ethyl-4-hydroxy-6-[3-(dimethylamino)-3,4,6-trideoxy-β-D-xylo-hexopyranosyloxy]-1-oxacyclohexadeca-11,13-diene-2,10-dione
- Antibiotic M-4365G3
- Juvenimicin B1
- Cirramycin A1, 12,13-deepoxy-12,13-didehydro-20-deoxo-4'-deoxy-20-hydroxy-
- 58947-83-4